AKT1 and Leigh syndrome: One such explanation implicates the shared activation of RAS/MAPK signaling in overlapping symptoms whereas distinct NS and LS features are the result of differences in PI3K/Akt pathway expression which is uniquely upregulated in LS patients and mouse models (Kontaridis et al., 2006; Serra-Nedelec et al., 2012).